Aligned to Lead (Aired 10-07-26) Ozempic and Vision Loss: GLP-1 Eye Risks Explained

October 13, 2026 • 00:53:42
Aligned to Lead (Aired 10-07-26) Ozempic and Vision Loss: GLP-1 Eye Risks Explained
Aligned to Lead (audio)
Aligned to Lead (Aired 10-07-26) Ozempic and Vision Loss: GLP-1 Eye Risks Explained

Oct 13 2026 | 00:53:42

/

Show Notes

In this episode of Aligned to Lead, host Dr. Megan Parks examines two critical areas that can affect high-performing leaders: executive burnout and emerging health concerns surrounding GLP-1 medications.

Dr. Parks begins by breaking down how burnout can remain hidden behind productivity, showing up as decision fatigue, chronic urgency, reduced creativity, poor delegation, and organizations that depend too heavily on one leader.

Other Episodes

Episode

July 29, 2026 • 00:50:26
Episode Cover

Aligned to Lead (Aired 07-29-26) Your Body Is Talking: The Hidden Signals You Should Never Ignore

In this compelling episode of Aligned to Lead, host Dr. Megan Parks welcomes Dr. Charita Cooper, CEO of Synergy Medical and president of the...

Listen

Episode

September 09, 2026 • 00:52:05
Episode Cover

Aligned to Lead (Aired 09-09-26) Back to Work After Cancer: The Challenges No One Sees

In this episode of Aligned to Lead, host Dr. Megan Parks welcomes Ada X. Chen, PhD, MPH, CRC, research scientist at the Center for...

Listen

Episode

June 24, 2026 • 00:48:05
Episode Cover

Aligned to Lead (Aired 06-24-26): Why High Achievers Stay Sick, Stressed and Stuck

In this episode of Aligned to Lead, host Dr. Megan Parks welcomes Dr. Raquel Yarroch for an insightful conversation on why so many high-achieving...

Listen